Latest Prescription Drugs news
Study Explores Impact of FDA Approval of Aducanumab on Trial Participation
posted December 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Bevacizumab, Aflibercept Compared for Neovascular AMD
posted December 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA: No Useful Monoclonal Antibody Treatments Left Against New COVID-19 Variants
posted December 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
No Significant Association Found for ADHD Meds, CVD Risk
posted December 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
t water
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Low Levels of Placental Growth Factor in Pregnancy Linked to Subsequent ADHD in Offspring .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
